Hawaii Health Digest: Press Releases

Triumph Steps Expands Emotional Literacy Programs to Schools Nationwide

Miami, Florida , Oct. 07, 2025 (GLOBE NEWSWIRE) -- Triumph Steps, an emotional literacy platform trusted by professionals and communities, today announced the national rollout of Triumph Steps for Schools, a comprehensive K–12 initiative designed to foster …

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it …

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …

Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)

- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, together with results from Neurona’s ongoing Phase 1/2 …

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Nature’s Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis

LEHI, Utah, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the relaunch of its Power Line suite of …

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing …

Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025

Présentation d’une comparaison entre histologie numérique et sur lame des biopsies de screening de l’étude de Phase 3 NATiV3 Présentation de pathologie numérique de données précliniques avec lanifibranor Daix (France), New York City (New York, United …

Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025

Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 study Presentation of digital pathology data from preclinical studies with lanifibranor Daix (France), New York City (New York, United …

AAVantgarde announces 3 presentations at ESGCT 2025 annual meeting

MILAN, Oct. 07, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced three presentations at the European Society of Gene …

NJ-Founded MetasTx Fast-Tracks Precision Approach to Stop Prostate Cancer Spread; NCI-Backed Diagnostic in Proof-of-Concept, Next-Gen KIT Inhibitor Advancing Toward First-in-Human

PITTSBURGH, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MetasTx, an early-stage biotech originally founded in New Jersey and now headquartered in Pittsburgh, announced progress on its two-part precision oncology platform designed to identify and treat men with …

Intermountain Primary Children’s Hospital Ranked as One of the Nation’s Best Pediatric Hospitals in Every Category by U.S. News & World Report

SALT LAKE CITY, Oct. 07, 2025 (GLOBE NEWSWIRE) -- A Utah medical milestone has been achieved by Intermountain Primary Children’s Hospital – one that directly benefits children and families throughout the Intermountain West.  For the second consecutive year …

Obesity Surgery Program Led by Dr. Mesut Caynak Expands Adoption of the ‘Caynak Technique’; SRC Master Accreditation Renewed

Photo: Dr. Mesut Caynak ANTALYA, Turkey, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The bariatric and metabolic surgery program led by Dr. Mesut Caynak announced the broader clinical adoption of the “Caynak Technique”, a systems-based, protocolized model for …

Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease

Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease Trial meets all primary and secondary endpoints establishing a strong foundation to Phase 2  The clinical trial demonstrated that both …

Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight

New York, USA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift …

Healthcare PPE Industry to Surpass $13 Billion by 2030 Amid Rising Safety Standards

Boston, Oct. 07, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Healthcare Personal Protective Equipment: Global Markets” is projected to grow from $10.3 billion in 2025 to $13.1 billion by the end of 2030, at a compound annual …

NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology

GAINESVILLE, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeXtGen Biologics announces the issuance of a third U.S. patent, US12311079, on May 27, 2025, as part of its suite of U.S. and foreign patents directed to extracellular matrix components derived from a …

Gift of Life Marrow Registry Partners With Miami Beach First Responders During Hispanic Heritage Month to Grow and Diversify Donor Registry

BOCA RATON, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- This Hispanic Heritage Month, Gift of Life Marrow Registry teamed up with the Miami Beach Police and Fire Departments to host the inaugural “Battle of the Badges” on October 5 at Fire Station 2 in Miami …

BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing

LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMed™, a next-generation cognitive-support dietary supplement formulated to support memory, focus, mental clarity, and …